Figure 2. Profile of autoantibodies against the 29 proteins detected in human plasma with APS-90. The autoantibodies detected were against the following proteins; thymic stromal lymphopoietin (THYM), osteoprotegerin (OPG), procalcitonin (PROC), resistin (RES), prolactin (PROL), interleukin-31 (IL-31), interleukin-29 (IL-29), interleukin-2 (INT2), galectin-1 (GAL1), flt3-ligand (FLT3), epiregulin (EPI), allograft inflammatory factor 1 (AIF), angiopoietin-like protein 3 (AL3), epidermal growth factor (EGF), cytotoxic t-lymphocyte associated antigen-4 (CYT), epigen (EPIG), growth hormone (GRH), interleukin-9 (IL-9), vascular endothelial growth factor (VEGF), p53 mutant (a.a 135) protein (p53), macrophage migration inhibitor factor (MMIF), prostaglandin d2 synthase (PD2S), activin-a (ACT-A), fibroblast growth factor 12 (FGF12), survivin (SUR), interleukin-33 human (IL33), progranulin (PROG), thyroglobulin human (THYR) and set7/9 histone methyltransferase (SET79). Out of these, osteoprotegerin, interleukin-2, vascular endothelial growth factor and macrophage migration inhibitor factor occurred at significantly different levels between the “test” and “reference” samples.